Cybernic treatment with wearable cyborg Hybrid Assistive Limb (HAL) improves ambulatory function in patients with slowly progressive rare neuromuscular diseases: a multicentre, randomised, controlled crossover trial for efficacy and safety (NCY-3001).

Orphanet J Rare Dis · 2021 · PMC8261928 · PMID 34233722

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

clearly significantno p-value reported

The PRO improvement effect of both the treatment 1 (hoist only) and 2 (HAL) on post–pre and post-then in the first period (V13–V4), and on post–pre in the first + second period (V24–V4) in group A and B was clearly significant.

also in 627 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.